aftopurdoe - search results

puri-nethol tablets 50 mg

padagis israel agencies ltd, israel - mercaptopurine - tablets - mercaptopurine 50 mg - mercaptopurine - mercaptopurine - for the treatment of acute leukemia and also in cases of chronic myelogenous leukemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

allmercap mercaptopurine monohydrate 20mg/ml oral liquid suspension bottle

link medical products pty ltd t/a link pharmaceuticals - mercaptopurine monohydrate, quantity: 20 mg/ml - oral liquid, suspension - excipient ingredients: xanthan gum; aspartame; rubus idaeus; sodium methyl hydroxybenzoate; sodium ethyl hydroxybenzoate; potassium sorbate; sodium hydroxide; purified water - allmercap oral liquid suspension is indicated for: treatment of acute lymphoblastic leukaemia (all) in paediatric patients.

Malta - English - Medicines Authority

mercaptopurine 50mg tablets

central procurement & supplies unit - mercaptopurine - tablet - mercaptopurine 50 milligram(s) - antineoplastic agents

New Zealand - English - Medsafe (Medicines Safety Authority)

mercaptopurine bnm

boucher & muir (new zealand) limited t/a bnm group - mercaptopurine 50mg - tablet - 50 mg - active: mercaptopurine 50mg excipient: lactose magnesium stearate maize starch pregelatinised maize starch stearic acid - mercaptopurine is indicated for the treatment of acute leukaemia in adults, adolescents and children. it may be utilised in remission induction and is particularly indicated for maintenance therapy in: · acute lymphoblastic leukaemia; · acute myelogenous leukaemia.